http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113897331-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-155 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0695 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074 |
filingDate | 2021-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2023-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2023-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113897331-B |
titleOfInvention | A method for inducing differentiation of human arterial endothelial cells |
abstract | The invention provides a method for inducing differentiation of human arterial endothelial cells, which belongs to the field of biotechnology. The differentiation method is as follows: using endothelial cell culture medium to adhere to culture endothelial progenitor cells for 0-1 day; using endothelial cell basal medium added with vascular endothelial growth factor and norepinephrine to continuously culture the endothelial progenitor cells 1-3 passages to obtain the induced human arterial endothelial cells. The arterial endothelial cells prepared by the invention are consistent with the adult arterial endothelial cells in terms of phenotype and function, and the experiment cycle is short, the cost is low, and the operation is easy. The invention can provide a source of specific arterial endothelial cells for in vitro vascular disease research, vascular disease treatment and drug development, as well as the construction of endothelialized tissue engineering blood vessels. |
priorityDate | 2021-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.